BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 25, 2007
View Archived Issues
Novartis rounds up 2006
Read More
Novel metabolic drugs described in recent patent literature
Read More
Novel antiinfective agents disclosed in recent patent literature
Read More
Recent patents disclose novel therapeutic options for neurological disorders
Read More
ThermoDox phase I data suggest manageable toxicity; patient accrual continues
Read More
Kiadis acquires research assets related to Wnt-signal transduction pathway
Read More
elbion acquires product candidates from DrugAbuse Sciences
Read More
Coley suspends independent development of Actilon for HCV
Read More
Milestone in Acumen and Merck's Alzheimer's collaboration
Read More
Medarex and Compugen collaborate on therapeutic antibody development
Read More
MN-305 studied for insomnia in new phase II trial
Read More
New phase II trial studies Davanat with 5-FU for advanced biliary cancer
Read More
NT-proBNP Test commercially launched in Europe
Read More
Launch of pharmacogenetic test for clozapine-induced agranulocytosis
Read More
Positive phase III findings for Akten in ocular anesthesia
Read More
Affectis inlicenses cimicoxib for CNS disorders
Read More
Pivotal phase III grass allergy trial of Pollinex Quattro begins
Read More
GSKbeta/catenin pathway accounted for radiosensitization of pancreatic cancer
Read More
U.K. clearance for phase III trials of CUV-1647 in polymorphous light eruption
Read More
University of Illinois researchers funded to develop new bipolar disorder drug
Read More
FDA action letter received for immunosuppressant FK-506 MR
Read More
Clinical data on AZD-2171 presented at GI Cancer Symposium
Read More
Novel sigma2 receptor ligands may be useful against pancreatic cancer
Read More
Clinical update on NV-1020
Read More
Notch signaling disruption sensitizes colon cancer cells to oxaliplatin
Read More
Approvable letter for Pristiq for major depressive disorder
Read More
Fresenius seeks approval for PhosLo in patients with Stage 4 chronic kidney disease
Read More